Abstract
Background & Aims: Therapeutic targets in ulcerative colitis (UC) have evolved over time from clinical remission to biological and endoscopic remission. Histologic remission remains a debatable outcome due to lack of data regarding its impact on long-term evolution. The development of histologic activity scores has brought standardization. We aimed to identify mucosal markers differentiating histological inflammation from histological remission in UC patients. Methods: The gene expression levels of 84 genes associated with inflammatory bowel diseases have been analyzed in 43 colonic mucosa samples from 30 patients with UC. The gene expression levels have been correlated with histological inflammation score of Geboes. Patients with endoscopic remission were divided by histological activity into two groups and molecular results were compared in order to identify differences in the mucosal gene expression. Results: We found a significant Pearson correlation (p<0.001 and r>0.5) between the Geboes score and the expression of 29 genes, whereas negative correlation (p<0.001 and r
Author supplied keywords
Cite
CITATION STYLE
Manuc, M., Ionescu, E. M., Milanesi, E., Dobre, M., Tieranu, I., Manuc, T. E., … Becheanu, G. (2020). Molecular signature of persistent histological inflammation iulcerative colitis with mucosal healing. Journal of Gastrointestinal and Liver Diseases, 29(2), 159–166. https://doi.org/10.15403/jgld-576
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.